Validation of a Digital Platform for Functional Respiratory Rehabilitation (ReHub)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Chronic Obstructive Pulmonary Disease (COPD), characterized by persistent airflow limitation in the respiratory airways, is a chronic condition that affects millions of people worldwide. ReHub enables healthcare professionals to design therapeutic exercise programs for the treatment of COPD patients, as well as to analyze and monitor patient rehabilitation through the information and feedback provided via the platform. The main objective of the study is to evaluate the satisfaction and usability of the ReHub platform (for respiratory rehabilitation) among COPD patients and healthcare professionals. This is a single-center satisfaction and usability study on the usage and experience of the ReHub platform (for respiratory rehabilitation).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with COPD, GOLD grade I - IV

• Need of respiratory rehabilitation.

• 18 years of age or older.

• Explicit willingness to participate in the study.

• Diagnosis of COPD (FEV1/FVC \< 70)

Locations
Other Locations
Spain
Hospital de la Santa Creu i Sant Pau
RECRUITING
Barcelona
Contact Information
Primary
Carme Puy, MD
mpuyr@santpau.cat
+34935565972
Time Frame
Start Date: 2024-03-07
Estimated Completion Date: 2024-12
Participants
Target number of participants: 100
Treatments
Experimental: ReHub
ReHub is a medical device designed to assist rehabilitation professionals by providing information for the design, monitoring, and analysis of therapeutic exercise programs for respiratory functional rehabilitation. Patients use the platform to follow the exercise program designed by their therapist from the location that suits them best.
Sponsors
Leads: Bio-Sensing Solutions S.L. (DyCare)
Collaborators: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Centre de Validació Clínica de Solucions Digitals

This content was sourced from clinicaltrials.gov